ISPH: Summary for Inspire Pharmaceuticals, Inc. - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Tuesday, November 24, 2009, 5:49am EST - Canadian Markets open in 3 hours and 41 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Inspire Pharmaceuticals, Inc. (ISPH)

On Nov 23: 5.23 USD 0.00 (0.00%)

MORE ON ISPH

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Inspire Pharmaceuticals, Inc. (NGM:ISPH) Delayed quote data

Last Trade:	5.23 USD
Trade Time:	Nov 23
Change:	0.00 (0.00%)
Prev Close:	5.23
Open:	N/A
Bid:	N/A
Ask:	N/A
1y Target Est:	9.63

Day's Range:	N/A - N/A
52wk Range:	2.59 - 6.54
Volume:	0
Avg Vol (3m):	626,357
Market Cap:	430.43M
P/E (ttm):	N/A
EPS (ttm):	-0.78
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Add ISPH to Portfolio

Download Data

HEADLINES

•	INSPIRE PHARMACEUTICALS INC Financials
	EDGAR Online Financials (Fri, Nov 13)

•	Local stocks rise as Wall Street surges
	at bizjournals.com (Mon, Nov 9)

•	Zacks Bull and Bear of the Day Highlights: Inspire Pharmaceuticals, Inc., Sears Holdings, Moody's Corp., CBS Corporation and Forest Oil Corporation
	Zacks.com (Mon, Nov 9)

•	Inspire Pharmaceuticals, Inc. (ISPH)
	Zacks.com (Mon, Nov 9)

•	New Star Analyst Rankings for Inspire Pharmaceuticals, Inc.
	StarMine (Sun, Nov 8)

•	INSPIRE PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Fri, Nov 6)

•	Higher revenue trims Inspireâs 3Q loss
	at bizjournals.com (Thu, Nov 5)

•	Inspire Pharmaceuticals Earnings Call scheduled for 10:00 am ET today
	CCBN (Thu, Nov 5)

•	INSPIRE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a
	EDGAR Online (Thu, Nov 5)

•	Q3 2009 Inspire Pharmaceuticals Earnings Release - Before Market Open
	CCBN (Thu, Nov 5)

•	Inspire Reports Third Quarter 2009 Financial Results
	Business Wire (Thu, Nov 5)

•	Inspire Completes Patient Enrollment in Three Late-Stage Clinical Trials in Cystic Fibrosis, Dry Eye and Blepharitis
	Business Wire (Wed, Nov 4)

More Headlines for ISPH...

ANALYST

EPS Est (next year) (Dec-09) :	-0.70
EPS Est (in 2 years) (Dec-10) :	-0.53
Avg Rec (current)*:	2.0
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Inspire Pharmaceuticals, Inc., a biopharmaceutical company, engages in researching, developing, and commercializing prescription pharmaceutical products for ophthalmic and pulmonary diseases.

Full Company Profile

Add to Portfolio

Email to a Friend

•